ArticleJournal of hepatocellular carcinoma2023

The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization.

Hao-Huan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.